Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v2.4.0.8
CONDENSED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2013
Dec. 31, 2012
Assets    
Cash $ 8,998 $ 18,102
Receivables 4,590 4,646
Prepaid expenses and other current assets 262 687
Total current assets 13,850 23,435
Property and equipment, net 1,670 1,392
Total assets 15,520 24,827
Liabilities and Stockholders' Equity (Deficit)    
Accounts payable 5,293 3,767
Accrued clinical trials expenses 423 532
Other accrued liabilities 306 219
Deferred contract revenue 6,228 14,375
Current portion of long-term debt, net of discount 0 2,500
Total current liabilities 12,250 21,393
Warrant liabilities 2,248 8,240
Royalty liability 0 8,962
Long-term debt, net of discount 0 9,360
Total liabilities 14,498 47,955
Commitments and contingencies      
Stockholders' deficit:    
Common stock, at amounts paid-in 279,560 265,986
Additional paid-in capital 21,670 21,014
Accumulated deficit (300,208) (310,128)
Total stockholders' equity (deficit) 1,022 (23,128)
Total liabilities and stockholders' equity (deficit) $ 15,520 $ 24,827